Children with Neuromuscular Disorders

  • Aviv D. GoldbartEmail author
Part of the Respiratory Medicine book series (RM)


Neuromuscular disorders (NMD) in children include a diverse group of diseases with different etiologies including muscular dystrophies, disorders of the neuromuscular junction, congenital and metabolic myopathies, peripheral neuropathies, and anterior horn cell disease. Patients with NMD are particularly vulnerable to sleep-related dysfunction. Sleep-disordered breathing often precedes diurnal respiratory failure in NMD patients, requiring timely recognition and management with noninvasive ventilation (NIV). This chapter reviews the mechanisms, diagnostic evaluation, and management of various neuromuscular diseases, with emphasis on nocturnal breathing problems.


Muscular Dystrophy Duchenne Muscular Dystrophy Neuromuscular Disease Duchenne Muscular Dystrophy Myotonic Dystrophy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    American Thoracic Society. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med. 2004;170(4):456–65.CrossRefGoogle Scholar
  2. 2.
    Gozal D. Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy. Pediatr Pulmonol. 2000;29(2):141–50.PubMedCrossRefGoogle Scholar
  3. 3.
    Harper PS. Myotonic dystrophy. 2nd ed. London: WB Saunders; 1989.Google Scholar
  4. 4.
    Hirschhorn R, Reuser AJJ. Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency. In: Scriver CR, Beaudet AL, Sly WS, et al., editors. The metabolic and molecular bases of inherited disease. New York: McGraw Hill; 2001. p. 3389–420.Google Scholar
  5. 5.
    Kirschner J, Bonnemann CG. The congenital and limb girdle muscular dystrophies: sharpening the focus, blurring the boundaries. Arch Neurol. 2004;61:189–99.PubMedCrossRefGoogle Scholar
  6. 6.
    DiMauro S. Mitochondrial diseases. Biochim Biophys Acta. 2004;23:80–8.Google Scholar
  7. 7.
    Shelton GD, Engvall E. Canine and feline models of human inherited muscle diseases. Neuromusc Disord. 2005;15:127–38.PubMedCrossRefGoogle Scholar
  8. 8.
    Kapsa R, Kornberg AJ, Byrne E. Novel therapies for Duchenne muscular dystrophy. Lancet Neurol. 2003;2:299–310.PubMedCrossRefGoogle Scholar
  9. 9.
    Muntoni F, Voit T. The congenital muscular dystrophies in 2004: a century of exciting progress. Neuromusc Disord. 2004;14:635–49.PubMedCrossRefGoogle Scholar
  10. 10.
    Kishnani PS, Howell RR. Pompe disease in infants and children. J Pediatr. 2004;144 Suppl 5:S35–43.PubMedGoogle Scholar
  11. 11.
    Taylor RW, Schaefer AM, Barron MJ, McFarland R, Turnbull DM. The diagnosis of mitochondrial muscle disease. Neuromusc Disord. 2004;14:237–45.PubMedCrossRefGoogle Scholar
  12. 12.
    Hogg JC, Williams J, Richardson JB, Macklem PT, Thurlbeck WM. Age as a factor in the distribution of lower-airway conductance and in the pathologic anatomy of obstructive lung disease. N Engl J Med. 1970;282:1283–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Papastamelos C, Panitch HB, England SE, Allen JL. Developmental changes in chest wall compliance in infancy and early childhood. J Appl Physiol. 1995;78:179–84.PubMedGoogle Scholar
  14. 14.
    Papastamelos C, Panitch HB, Allen JL. Chest wall compliance in infants and children with neuromuscular disease. Am J Respir Crit Care Med. 1996;154:1045–8.PubMedGoogle Scholar
  15. 15.
    Simonds AK. Paediatric non-invasive ventilation. In: Simonds AK, editor. Non-invasive respiratory support. 2nd ed. London: Arnold; 2001. p. 177–202.Google Scholar
  16. 16.
    Chatwin M, Ross E, Hart N, Nickol AH, Polkey MI, Simonds AK. Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness. Eur Respir J. 2003;21:502–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Bach JR, Smith WH, Michaels J, et al. Airway secretion clearance by mechanical exsufflation for post-poliomyelitis ventilator-assisted individuals. Arch Phys Med Rehabil. 1993;74:170–7.PubMedGoogle Scholar
  18. 18.
    Deakins K, Chatburn RL. A comparison of intrapulmonary percussive ventilation and conventional chest physiotherapy for the treatment of atelectasis in the pediatric patient. Respir Care. 2002;47:1162–7.PubMedGoogle Scholar
  19. 19.
    Katz S, Selvadurai H, Keilty K, Mitchell M, MacLusky I. Outcome of non-invasive positive pressure ventilation in paediatric neuromuscular disease. Arch Dis Child. 2004;89:121–4.PubMedCrossRefGoogle Scholar
  20. 20.
    Vianello A, Bevilacqua M, Salvador V, Cardaioli C, Vincenti E. Long-term nasal intermittent positive pressure ventilation in advanced Duchenne’s muscular dystrophy. Chest. 1994;105:445–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Simonds AK, Ward S, Heather S, Bush A, Muntoni F. Outcome of paediatric domiciliary mask ventilation in neuromuscular and skeletal disease. Eur Respir J. 2000;16:476–81.PubMedCrossRefGoogle Scholar
  22. 22.
    Bach JR, Niranjan V, Weaver B. Spinal muscular atrophy type I: a noninvasive respiratory management approach. Chest. 2000;117:1100–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Khan Y, Heckmatt JZ, Dubowitz V. Sleep studies and supportive ventilatory treatment in patients with congenital muscle disorders. Arch Dis Child. 1996;74: 195–200.PubMedCrossRefGoogle Scholar
  24. 24.
    Raphael JC, Chevret S, Chastang C, Bouvet F. Randomized trial of preventative nasal ventilation in Duchenne muscular dystrophy. French Multicentre Cooperative Group on home mechanical ventilation assistance in Duchenne de Boulogne muscular dystrophy. Lancet. 1994;343:1600–4.PubMedCrossRefGoogle Scholar
  25. 25.
    Ward S, Chatwin M, Heather S, Simonds AK. Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax. 2005;60:1019–24.PubMedCrossRefGoogle Scholar
  26. 26.
    Limeres J, Diz P, Vilaboa C, Tomas I, Feijoo JF. Individualized nasal mask fabrication for positive pressure ventilation using dental methods. Int J Prosthodont. 2004;17:247–50.PubMedGoogle Scholar
  27. 27.
    Fauroux B, Lavis JF, Nicot F, et al. Facial side effects during noninvasive positive pressure ventilation in children. Intensive Care Med. 2005;31:965–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Guilleminault C, Philip P, Robinson A. Sleep and neuromuscular disease: bilevel positive airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular disease. J Neurol Neurosurg Psychiatry. 1998;65:225–32.PubMedCrossRefGoogle Scholar
  29. 29.
    Friedman O, Chidekel A, Lawless ST, Cook SP. Postoperative bilevel positive airway pressure ventilation after tonsillectomy and adenoidectomy in children–a preliminary report. Int J Pediatr Otorhinolaryngol. 1999;51:177–80.PubMedCrossRefGoogle Scholar
  30. 30.
    Chernick V, Kendig EL. Disorders of the respiratory tract in children. W.B. Saunders Company; 1990. p. 666, Philadelphia PA.Google Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  1. 1.Sleep Wake Disorders Unit, Department of Pediatrics, Saban Pediatric CenterSoroka University Medical CenterBeer-ShevaIsrael

Personalised recommendations